The systemic administration of oleoylethanolamide exerts neuroprotection of the nigrostriatal system in experimental parkinsonism
González Aparicio, Ramiro José
Pavón, Francisco Javier
Parsons, Loren H.
Fernández Espejo, Emilio
Rodríguez de Fonseca, Fernando
MetadataShow full item record
Oleoylethanolamide (OEA) is an agonist of the peroxisome proliferator-activated receptor α (PPARα) and has been described to exhibit neuroprotective properties when administered locally in animal models of several neurological disorder models, including stroke and Parkinson's disease. However, there is little information regarding the effectiveness of systemic administration of OEA on Parkinson's disease. In the present study, OEA-mediated neuroprotection has been tested on in vivo and in vitro models of 6-hydroxydopamine (6-OH-DA)-induced degeneration. The in vivo model was based on the intrastriatal infusion of the neurotoxin 6-OH-DA, which generates Parkinsonian symptoms. Rats were treated 2 h before and after the 6-OH-DA treatment with systemic OEA (0.5, 1, and 5 mg/kg). The Parkinsonian symptoms were evaluated at 1 and 4 wk after the development of lesions. The functional status of the nigrostriatal system was studied through tyrosine-hydroxylase (TH) and hemeoxygenase-1 (HO-1, oxidation marker) immunostaining as well as by monitoring the synaptophysin content. In vitro cell cultures were also treated with OEA and 6-OH-DA. As expected, our results revealed 6-OH-DA induced neurotoxicity and behavioural deficits; however, these alterations were less severe in the animals treated with the highest dose of OEA (5 mg/kg). 6-OH-DA administration significantly reduced the striatal TH-immunoreactivity (ir) density, synaptophysin expression, and the number of nigral TH-ir neurons. Moreover, 6-OH-DA enhanced striatal HO-1 content, which was blocked by OEA (5 mg/kg). In vitro, 0.5 and 1 μM of OEA exerted significant neuroprotection on cultured nigral neurons. These effects were abolished after blocking PPARα with the selective antagonist GW6471. In conclusion, systemic OEA protects the nigrostriatal circuit from 6-OH-DA-induced neurotoxicity through a PPARα-dependent mechanism.
Is part ofInternational Journal of Neuropsychopharmacology, 2014, vol. 17, núm. 3, p. 455-468
European research projects
Except where otherwise noted, this item's license is described as cc-by-nc (c) Collegium Internationale Neuro-Psychopharmacologicum (CINP) , 2014
Showing items related by title, author, creator and subject.
Oleoylethanolamide restores alcohol-induced inhibition of neuronal proliferation and microglial activity in striatum Rivera, Patricia; Silva Peña, Daniel; Blanco Calvo, Eduardo; Vargas, Antonio; Arrabal, Sergio; Serrano, Antonia; Pavón, Francisco Javier; Bindila, Laura; Lutz, Beat; Rodríguez de Fonseca, Fernando; Suárez, Juan (Elsevier, 2019-03-01)Previous findings demonstrate a homeostatic role for oleoylethanolamide (OEA) signaling in the ethanol-related neuroinflammation and behavior. However, extensive research is still required in order to unveil the effects ...
Evaluation of plasma-free endocannabinoids and their congeners in abstinent cocaine addicts seeking outpatient treatment: impact of psychiatric co-morbidity Pavón, Francisco Javier; Araos, Pedro; Pastor, Antoni; Calado, Montserrat; Pedraz, María; Campos Cloute, Rafael; Ruiz, Juan Jesús; Serrano, Antonia; Blanco Calvo, Eduardo; Rivera, Patricia; Suárez, Juan; Romero-Cuevas, Miguel; Pujadas, Mitona; Vergara-Moragues, Esperanza; Gornemann, Isolde; Torrens, Marta; De la Torre, Rafael; Rodríguez de Fonseca, Fernando (John Wiley & Sons, 2013-11-14)Cocaine is associated with serious health problems including psychiatric co-morbidity. There is a need for the identification of biomarkers for the stratification of cocaine-addicted subjects. Several studies have evaluated ...
Diet-dependent modulation of hippocampal expression of endocannabinoid signaling-related proteins in cannabinoid antagonist-treated obese rats Rivera, Patricia; Luque-Rojas, María Jesús; Pastor, Antoni; Blanco Calvo, Eduardo; Pavón, Francisco Javier; Serrano, Antonia; Crespillo, Ana; Vida, Margarita; Grondona, Jesús M.; Cifuentes, Manuel; Bermúdez-Silva, Francisco J.; De la Torre, Rafael; Rodríguez de Fonseca, Fernando; Suárez, Juan (Federation of European Neuroscience Societies and John Wiley & Sons, 2013-01-00)Diet-induced obesity produces changes in endocannabinoid signaling (ECS), influencing the regulation of energy homeostasis. Recently, we demonstrated that, in high-fat-diet-fed rats, blockade of CB1 receptor by AM251 not ...